Liminatus Pharma LLCLIMN
13F holders, Q1 2026 (March 31)15holders +3
4new positions
2sold out
1famous investor
$0.17avg. 13F price*
At the end of Q1 2026, 15 institutions reported holding Liminatus Pharma LLC (LIMN) in their 13F filings, up 3 from Q4 2025. 4 opened new positions and 2 sold out. The largest holders were Citadel Advisors ($116K), Cygnus Capital Advisors, LLC ($60K) and Geode Capital Management, LLC ($20K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Liminatus Pharma LLC
- CUSIP
- 53271X108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q4 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $83K |
| Exits | 2 | $22K |
All 13F filers, Q4 2025 → Q1 2026: 1,194,927 shares bought and 36,682 shares sold, net +1,158,245 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 15 holders
| Citadel Advisors | 0.00% | Add +855.2% | 677,518 | $116K |
| Cygnus Capital Advisors, LLC | 0.04% | New | 350,000 | $60K |
| Geode Capital Management, LLC | 0.00% | Add +81.1% | 117,783 | $20K |
| Jane Street Group, LLC | 0.00% | New | 71,318 | $12K |
| UBS Group AG | 0.00% | Add +181.4% | 54,578 | $9K |
| Vanguard Capital Management LLC | 0.00% | — | 50,440 | $9K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 34,706 | $6K |
| Virtu Financial LLC | 0.00% | New | 27,468 | $5K |
| Vanguard Fiduciary Trust Co. | 0.00% | — | 22,984 | $4K |
| Two Sigma Securities, LLC | 0.00% | Add +85.6% | 22,039 | $4K |
| State Street Corp. | 0.00% | No change | 19,000 | $3K |
| BlackRock, Inc. | 0.00% | Reduce -0.0% | 13,254 | $2K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -15.0% | 7,567 | $1K |
| Citigroup Inc. | 0.00% | Add +676800.0% | 6,769 | $1K |
| Farther Finance Advisors, LLC | 0.00% | Reduce -54.8% | 14 | $2 |
"% of holder's portfolio" is LIMN's weight in each manager's 13F, not the share of Liminatus Pharma LLC the manager owns.